Old Web
English
Sign In
Acemap
>
authorDetail
>
AnnKatrin Petersen
AnnKatrin Petersen
Bristol-Myers Squibb
Ulcerative colitis
Internal medicine
Medicine
Gastroenterology
Ozanimod
3
Papers
11
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ozanimod for moderate-to-severe Ulcerative Colitis (UC): efficacy, safety, and histology results from the induction and maintenance periods of the Phase 3 TRUE NORTH Study
2021
Britta Siegmund
W. J. Sandborn
G R D’Haens
D. Wolf
Stephen B. Hanauer
I. Jovanovic
Subrata Ghosh
AnnKatrin Petersen
Lorna Charles
D.K. Chitkara
Brian G. Feagan
S. Danese
Show All
Source
Cite
Save
Citations (0)
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
2021
The New England Journal of Medicine
William J. Sandborn
Brian G. Feagan
Geert R. DHaens
Douglas C. Wolf
Igor Jovanovic
Stephen B. Hanauer
Subrata Ghosh
AnnKatrin Petersen
Steven Y Hua
Ji Hwan Lee
Lorna Charles
Denesh K. Chitkara
Keith Usiskin
Jean-Frederic Colombel
Loren Laine
Silvio Danese
Show All
Source
Cite
Save
Citations (3)
Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Results From The Open-Label Extension Of The Randomized, Phase 2 Touchstone Study.
2021
Journal of Crohns & Colitis
William J. Sandborn
Brian G. Feagan
Stephen B. Hanauer
Severine Vermeire
Subrata Ghosh
Wenzhong J Liu
AnnKatrin Petersen
Lorna Charles
Vivian Huang
Keith Usiskin
Douglas C. Wolf
Geert R. DHaens
Show All
Source
Cite
Save
Citations (8)
1